PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES

A compound having the structure: (see formulaI) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or a pharmaceutically acceptable solvate of the pharmaceutically acceptable salt of the compound. Also provided is a use of a compound of the inven...

Full description

Saved in:
Bibliographic Details
Main Authors GERSTENBERGER, BRIAN STEPHEN, OWEN, DAFYDD RHYS, BROWN, MATTHEW FRANK, DERMENCI, ALPAY, YANG, XIAOJING, HAYWARD, MATTHEW MERRILL, WRIGHT, STEPHEN WAYNE, FENSOME, ANDREW, XING, LI HUANG
Format Patent
LanguageEnglish
French
Published 27.02.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A compound having the structure: (see formulaI) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or a pharmaceutically acceptable solvate of the pharmaceutically acceptable salt of the compound. Also provided is a use of a compound of the invention as a TYK2 inhibitor. Un composé est décrit, lequel présente la structure : (voir la formule I) ou un sel connexe acceptable sur le plan pharmaceutique ou un solvate acceptable sur le plan pharmaceutique du composé ou un solvate acceptable sur le plan pharmaceutique du sel acceptable sur le plan pharmaceutique du composé. Une utilisation du composé de linvention comme un inhibiteur de TYK2 est aussi décrite.
Bibliography:Application Number: CA20172958490